Company Registration number 10070362 Charity Registration number 1167247
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
TRUSTEES REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
Stephenson Coates Audit Limited
Chartered Accountants
West 2, Asama Court, Newcastle Business Park Newcastle upon Tyne, NE4 7YD
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
| Contents | |
|---|---|
| Page | |
| Reference and administrative details | 1 |
| Trustees' report | 2 - 8 |
| Independent examiner's report | 9 |
| Statement of financial activities | 10 |
| Balance sheet | 11 |
| Notes to the financial statements | 12 - 16 |
1
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Reference and administrative details Year ended 31 December 2023
Trustees and directors
Bilal, M Appointed 29 August 2024 Brittain, H Appointed 24 June 2024 Chaytor, P Appointed 24 June 2024 Cook, M Resigned 24 June 2024 Cumming, T Resigned 30 November 2023 Gleghorn, D Appointed 21 June 2024 Harker, D Lambert, I Appointed 30 November 2023 Lock, S Pickersgill, C Sewell, N Resigned 28 August 2024 Vadhera, S Resigned 30 November 2023
Registered office and operational address
West 2, Asama Court Newcastle Business park Newcastle upon Tyne NE4 7YD
Independend examiner
Peter J Alexander BSc Stephenson Coates Audit Limited Chartered Accountants & Registered Auditors West 2, Asama Court Newcastle Business park Newcastle upon Tyne, NE4 7YD
Bankers
Handelsbanken Winder House Kingfisher Way Stockton on Tees TS18 3EX Company number 10070362 Charity number 1167247
2
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Trustees' Report Year ended 31 December 2023
The trustees and directors of the company present their annual report together with the financial statements for the year to 31 December 2023.
The trustees confirm that the annual report and financial statements of the charity comply with the current statutory requirements, the requirements of the charity's governing document and the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102); and the Companies Act 2006.
Introduction
In the backdrop of another challenging year, 2023 presented numerous obstacles for young cancer patients and their families. Beyond grappling with cancer diagnoses, they faced the dual burdens of a cost-of-living crisis and the enduring aftermath of the pandemic.
Amid these external trials, Dragonfly Cancer Trust achieved significant progress throughout 2022. We deepened our engagement with supporters and stakeholders, forging stronger connections. Hospitals and hospices once again welcomed our effort to distribute activity boxes, benefiting countless young cancer patients undergoing treatment in bustling day units, IPU’s, and hospices.
Objectives and activities
The core principles of the Trust revolve around alleviating the needs of children and young individuals grappling with life-threatening or terminal illnesses, according to the discretion of the trustees.
"Our vision is to ensure that each moment matters for young cancer patients with limited time, providing them with the support and opportunities to create cherished memories that honour their lives and bring comfort to their journey."
The Trust supports young cancer patients aged from birth to 24 years who have received the unimaginable news that no further treatments options are available. Each request is centered on ensuring that patients and their families can create lasting memories together, facilitated through a range of services provided by Dragonfly Cancer Trust. These services include: - Cash Gifts - Activity Boxes - Sibling Boxes - Memory Boxes - Keepsakes such as glass hearts and fingerprint jewelry.
Healthcare Professionals submit requests across the NHS, hospices, and cancer charities like Teenage Cancer Trust and Young Lives vs Cancer and occasionally referrals may come directly from the families. We collaborate with medical teams to achieve the very best outcomes for young cancer patients under their care. Requests are submitted to the Trust via a secure server and their approval is overseen by the Trustees. The monetary amount granted is subject to the Trustees' discretion and is continually reviewed and monitored.
3
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Trustees' Report (continued) Year ended 31 December 2023
Our Impact and the difference we have made
Cash Gifts: Through our Cash Gifts, we have been able to provide immediate support to young cancer patients facing unimaginable circumstances. The cash can be used on a pain free day enabling a strong sense of control and independence. These gifts offer a sense of relief, allowing families to focus on spending precious time together without the added burden of financial stress.
Activity Boxes: Our specialist age-appropriate boxes are sent on a rolling basis to young people’s oncology wards and hospices throughout the country, many hundreds of young patients access the contents of the boxes, which provide s focus and distraction during lengthy periods of treatment.
Sibling Boxes/Memory Boxes: Understanding the impact of cancer on the entire family, our Sibling Boxes are thoughtfully curated to bring comfort to the brothers and sisters of young cancer patients. These boxes are filled with activities designed to bring a moment of escape, focus and a much-needed distraction during difficult times.
"The Sibling Box was such a wonderful surprise for our daughter. It helped her feel special and included during a time when so much attention was focused on her brother."
Glass Hearts: Our Glass Hearts have become a symbol of love, strength, and remembrance. Each heart is handcrafted with care, offering families a tangible reminder of the love they share. "The Glass Heart we received sits on our mantelpiece, a beautiful reminder of our son’s courage and the love that will always connect us."
Review of Activities and Financial Performance
2023 continued to be a challenging year for children and young people with cancer, and their families. This struggle related to the financial climate and cost-of-living crisis continuing to have a significant impact on young cancer patients and their families. The Board of Trustees were fully aware of this challenge and reviewed the risks and challenges associated.
We continued to communicate and strengthen our relationships with the Young Lives vs Cancer teams, ensuring they were aware of our services and any changes relating to the criteria and referral process. Teaming up with external healthcare professionals significantly boosted the visibility of Dragonfly Cancer Trust, leading to a notable increase in both awareness and referrals. By leveraging these professional networks, we have been able to reach a broader audience and ensure that more families in need are aware of and can access our services. This collaboration not only enhanced our outreach efforts but also strengthened our ability to provide crucial support to young cancer patients and their families.
Trustee Ian Lamberts’ world record attempt was a tremendous success, dramatically increasing our engagement across social media platforms. His challenge not only captured widespread attention but also energised our supporter base, leading to a surge in likes, shares, and comments. In response, actively enhanced. Our social media strategies to build on this momentum. By creating more compelling content, engaging with our audience more interactively, and expanding our presence across various channels, we were able to sustain and grow the enthusiasm generated by Ian’s remarkable achievement.
4
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Trustees' Report (continued) Year ended 31 December 2023
Public Benefit
During a strategy meeting of our aims and objectives and planning our future activities, Dragonfly Cancer Trust referred to and complied with the duty in section 17 of the Charities Act 2011. This relates to having due regard to the Charity Commission’s published general guidance on public benefit. In particular, the Trustees consider how planned activities will contribute to the aims and objectives they have set.
We continued our professional memberships with the Chartered Institute of Fundraising ensuring our compliance with The Code of Fundraising Practice. We also renewed our membership with the ICO to further increase the confidence of the public in our organisation and its ability to process information safely and legally. No fundraising complaints were received during 2023.
Collaborating with various organisations in 2023, we strengthened our partnerships with a multitude of health care providers to ensure that children and young people battling cancer, along with their families, had access to vital support and resources. Through these alliances, we enhanced the diversity, equity, and inclusivity of our services, creating an environment where everyone felt welcomed and supported.
Fundraising
In the wake of the pandemic, we adopted a balanced approach to our fundraising strategy, aiming to mitigate risks to the Trust. We upheld our commitment to maintaining a diverse portfolio of events and building on the success of 2022 we further widened our sources of funds. The Annual Ball and Great North Run continued to be major fundraising events. We would like to extend our sincere thanks to the following organisations, foundations, and individuals for their invaluable support:
Nucha: For their continued collaboration in their sponsorship of vests for our participants in the Great North Run, ensuring that our runners can proudly represent Dragonfly Cancer Trust in this iconic event.
Art Adventurer's: For selecting Dragonfly Cancer Trust as their chosen charity for 2023 and for their creative initiatives and fundraising efforts that have brought in much-needed resources.
St James's Place Foundation: For sponsoring one of our trustees through their foundation for the Sahara Challenge, a significant fundraising milestone for Dragonfly Cancer Trust.
Bopari Fund: For their generous donation and recognition of the important work that Dragonfly Cancer Trust does, making a tangible difference in our ability to provide support.
Wentworth Grange: For their continued support at our annual ball, helping us raise crucial funds while bringing our community together.
The Rothlay Trust: For the funding of our rent, providing us with the stability needed to focus on our mission without the added financial strain of operational costs.
Joseph Strong Frazer Trust: For their contribution to our core costs.
Kans and Kandy: For their unwavering support through The Big Give initiative, helping us raise essential funds to expand our services.
5
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Trustees' Report (continued)
Year ended 31 December 2023
Fundraise and Recycle: For their ongoing partnership, which has been crucial in generating additional resources for our mission.
The Newcastle upon Tyne Children’s Mission Fund: For their generous donation to support young cancer patients, enabling us to continue providing critical care and services.
Cabaret vs Cancer: For their ongoing support of our projects, helping us bring comfort to young cancer patients and their families.
Center Parcs: For their continued partnership enabling us to offer special breaks to families, giving them a break from their surroundings and offering a chance for the families to create lasting memories together.
We also want to extend a special thank you to our wonderful volunteers and incredible supporters. Without their dedication and passion, we would not be able to do what we do. Their tireless efforts and commitment make a world of difference to the young cancer patients and families we support.
Our Goals for 2024
As Dragonfly Cancer Trust looks ahead, we are committed to expanding our services and outreach to better support young cancer patients and their families. One of our key focuses will be to further development of our sibling boxes, incorporating new designs and expanding their reach across more regions. These boxes play a crucial role in recognising and supporting the siblings of young cancer patients, and by refining their design, we aim to enhance the experience for families across the UK.
In addition to this, we are dedicated to broadening our outreach to ensure that everyone is aware of Dragonfly Cancer Trust’s vital work. Our support for young cancer patients, from birth to 24 years, remains at the heart of everything we do. We will continue to collaborate with like-minded organisations to deliver our services with speed, compassion and dignity ensuring that no family faces the challenges of childhood cancer alone.
Dragonfly Cancer Trust is set to undertake a thorough review of its fundraising portfolio to incorporate new national treks and open challenges. This strategic evaluation will focus on diversifying our fundraising activities to engage a broader audience and enhance our financial support. We will systematically monitor and assess the impact of these changes, ensuring that each initiative aligns with our goals and effectively contributes to our mission. This ongoing review process will help us optimise our fundraising efforts and drive greater success in supporting young cancer patients and their families.
Measuring our effectiveness is key to our growth. We will collect feedback, set clear performance metrics, and evaluate our efforts in areas such as collaboration, visibility, patient engagement, and revenue generation. This data will inform future strategic decisions.
Our goal is to be widely recognized for the work we do, ensuring that every young cancer patient across the country knows that Dragonfly Cancer Trust is here to support them and their families through the most difficult times. Through these efforts, we hope to increase our impact and ensure no young cancer patient is left without the help they need.
6
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Trustees' Report (continued) Year ended 31 December 2023
• Continue to Expand Reach: Our primary objective is to reach a wider audience of those who require our support. To achieve this, we will employ a multi-faceted approach, integrating both online and offline channels. Our strategy includes developing a user-friendly website that offers comprehensive information about our services and the referral process. We will harness the power of social media platforms to connect with patients and their families while also enhancing our inperson presence within hospitals and healthcare establishments.
• Breaking Barriers: We acknowledge that one of the significant hurdles in accessing our services is a lack of awareness about the breadth of support we provide. Addressing this, we aim to clarify the scope of assistance available and foster the understanding that Dragonfly Cancer Trust is indeed relevant to their unique situations.
• Sustainable Growth: Our focus extends to ensuring the sustainable growth of our charity, enabling us to consistently support young cancer patients and their families.
• Collaboration for Impact: Collaboration remains a core strategy. We intend to work closely with other organizations and medical professionals to amplify the reach and impact of our initiatives.
• Elevate Profile: Enhancing our visibility is paramount to our mission. We will persist in utilising social media platforms, content marketing, and PR endeavors to share impactful success stories and relay feedback from both families and patients.
• Diverse Income Streams: Generating a diverse range of income sources is critical for the continued success of our initiatives. We are committed to exploring various avenues, including grants, individual donations, corporate partnerships, and fundraising events. Our refined fundraising strategy will emphasize how these contributions directly impact the lives of cancer patients.
• Measuring Impact: The pursuit of meaningful impact will continue to be a cornerstone. We will actively gather feedback, establish key performance indicators, and evaluate collaboration efforts, visibility enhancement, patient engagement, and income generation. The insights derived from these metrics will guide our strategic decisions.
• Engage Dedicated Volunteers: Our existing volunteer engagement strategy will be further refined to attract more volunteers who share our passion and are eager to contribute to the growth and development of the charity.
• Compelling Storytelling: We will continue to share the stories of young cancer patients who have benefited from our services, whenever possible. Feedback forms will be a key resource to gather these narratives, enabling us to create impactful content for future dissemination.
Organisational structure
The organisation was registered as a Company Limited by Guarantee on 17 March 2016 and as a Charity on 20 May 2016. The company was established under Memorandum and Articles of Association and a Charitable Trust deed which govern its objects and powers. In the event of the company being wound up members are required to contribute an amount not exceeding £10.
On September 7th, 2022, the Trust officially changed its name to Dragonfly Cancer Trust. This name had previously been used as our working name and the Trustees believed that this change would enhance clarity and strategically reposition our brand.
7
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Trustees' Report (continued) Year ended 31 December 2023
The Directors of the company are also charity trustees and the management of the organisation is their responsibility. They are appointed under the terms of the governing documents. Trustees are elected to serve for 2 years after which they are eligible for re-election at the next AGM.
The day-to-day operations are delegated to the CEO who leads a team of staff and volunteers. We are grateful to our many volunteers and supporters who make such a huge difference.
Dragonfly Cancer Trust will undertake a comprehensive review of its Board of Trustees to enhance its governance and strategic direction. As part of this initiative, we will be actively recruiting our first Digital Trustee to strengthen our expertise in the digital realm. Following a thorough skills assessment, we will be targeting trustee recruitment to address the specific needs of the charity, ensuring that each board member brings valuable skills and experience to support our mission effectively. This strategic approach aims to bolster our capacity to navigate the evolving landscape and drive our goals forward with greater impact.
We will continue to strengthen our volunteer engagement strategy to attract individuals who are passionate about our mission and eager to contribute to the charity’s growth and development. We will seek to continue our work with Newcastle University by providing Career Development Modules for students wishing to work within a charitable environment.
Reserves Policy
Our fundraising income streams are not constant nor guaranteed. In order to ensure continuity and stability for the staff, volunteers and beneficiaries, it is necessary to hold enough reserves to mitigate a short-term fall in income and enable continued operation for a period of six months.
The trustees consider the highest risks to be associated with the generation of unrestricted income, from which the core central costs, including staff salaries, are paid. Core organisational costs are reasonably static, however payments to beneficiaries are difficult to predict and some element of flexibility for this needs to be built into the level of reserves held.
The level of reserves held is therefore based upon the level of “core” costs for a six-month period, together with an additional amount set aside to allow for a 10% increase in the level of gifts awarded. After consideration of the above points, the trustees consider the appropriate level of unrestricted fund reserves to be £65,000.
Other Unrestricted Reserves
The capital reserve is adjusted annually to reflect the net book value of fixed assets, which cannot be easily realised, in the event of a cash shortfall.
Restricted Reserves
Where the Trust receives contributions that are restricted to particular types of expenditure any unused amounts are held in a restricted reserve. At the end of 2023, there were no restricted reserves.
8
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
Trustees' Report (continued) Year ended 31 December 2023
Risk Management
The trustees have assessed the major risks within a tailored risk register to which the charity is exposed, in particular those related to the operations and finances of the charity, and are satisfied that systems and procedures are in place to mitigate our exposure to the major risks.
Statement of the directors' responsibilities in relation to the financial statements
The directors are responsible for preparing the directors' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the directors to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the income and expenditure of the charitable company for that period.
In preparing these financial statements, the directors are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP;
-
make judgements and estimates that are reasonable and prudent; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.
The directors are responsible for keeping accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
This report has been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
Approved by the directors on 27 September 2024 and signed on their behalf by:
?????
Chair of Trustees and Company Director
REPORT OF THE INDEPENDENT EXAMINER TO THE DIRECTORS OF 9 DRAGONFLY CANCER TRUST LTD
I report on the financial statements for the year ended 31 December 2023, which comprise the statement of financial activities (including income and expenditure account), balance sheet and the related notes to the accounts.
Responsibilities and basis of report
As the charity’s trustees of the company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).
Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (the ‘2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner’s report
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1) accounting records were not kept in respect of the company as required by section 386 of the 2006 Act and, in any other case, section 130 of the Charities Act 2011; or
2) the accounts do not accord with those accounting records; or
3) the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair’ view which is not a matter considered as part of an independent examination; or
4) the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Peter Alexander BSc Date: 27 September 2024 Stephenson Coates Audit Limited Chartered Accountants West 2, Asama Court Newcastle Business Park Newcastle upon Tyne NE4 7YD
10
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital) Statement of financial activities
(Incorporating Income and Expenditure Account) Year ended 31 December 2023
| Note Income from Donations 2 Other trading activities 3 Total Income Expenditure on Raising funds 4 Charitable activities 5 Total expenditure Net incoming resources Transfer between Funds Total funds brought forward Total funds carried forward 11 |
Unrestricted funds Restricted funds Total funds Total funds 2023 2023 2023 2022 £ £ £ £ 88,108 8,500 96,608 74,124 81,637 - 81,637 83,559 169,745 8,500 178,245 157,683 26,042 - 26,042 23,654 131,325 9,081 140,406 141,778 157,367 9,081 166,448 165,432 12,378 (581) 11,797 (7,749) 4,419 (4,419) - - 78,947 5,000 83,947 91,696 95,744 - 95,744 83,947 |
|---|---|
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
The notes on pages 12 to 16 form part of these financial statements.
11
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital)
| Balance Sheet Year ended 31 December 2023 Note Fixed assets Tangible assets 9 Current assets Cash at bank and in hand Creditors: amounts falling due within one year 10 Net current assets Net assets Funds Restricted funds 11 Unrestricted funds 11 Total funds |
£ £ 891 95,553 95,553 700 94,853 95,744 - 95,744 95,744 31 December 2023 |
£ 1,048 85,408 85,408 2,509 82,899 83,947 5,000 78,947 83,947 31 December 2022 |
|---|---|---|
In approving these financial statements (which include the notes on pages 1 to 16) as directors of the charitable company, we hereby confirm:
(a) that for the period stated above the charitable company was entitled to the exemption conferred by Section 477 of the Companies Act 2006;
(b) that no notice has been deposited at the registered office of the charitable company pursuant to Section 476 requesting that an audit be conducted for the year ended 31 December 2023 and
(c) that we acknowledge our responsibilities for:
-
ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of the financial period and of its profit or loss for the period then ended in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the provisions of the Companies Act relating to financial statements, so far as applicable to the charitable company.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small entities regime of Financial Reporting Standard 102.
These financial statements were approved by the directors on 27 September 2024 and are signed on their behalf by:
??????? Director
Company registration number 10070362
12
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital) Notes to the financial statements Year ended 31 December 2023
1. Accounting policies
The principal accounting policies are summarised below. The accounting policies have been consistently applied.
1.1 Basis of preparation of financial statements
The Financial Statements have been prepared under the historical cost convention and in accordance with the Statement of Recommended Practice "Accounting and Reporting by Charities" applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102); and the Companies Act 2006 and the Charities Act 2011.
1.2 Fund accounting
General Funds are unrestricted funds which are available for use at the discretion of the trustees in furtherance of the general objectives of the charity and which have not been designed for other purposes.
Designated funds are general funds which have been set aside by the trustees for a specific purpose.
Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes.
The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.
1.3 Incoming resources
All incoming resources are included in the statement of financial activities when the charily has entitlement to the funds, certainty of receipt and the amount can be measured with sufficient reliability. For legacies, entitlement is the earlier of the charity being notified of an impending distribution or the legacy being received.
Gifts in kind are included in the statement of financial activities at a reasonable estimate of their value at the time they are utilised by the charity, with the equivalent amount recognised as charitable expenditure. No amounts are included in the financial statements for services donated by volunteers.
Donated services or facilities, which comprise donated services, are included in income at a valuation which is an estimate of the financial cost borne by the donor where such a cost is quantifiable and measurable. No income is recognised where there is no financial cost borne by a third party.
Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of donation.
13
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital) Notes to the financial statements (continued) Year ended 31 December 2023
1.4 Resources expended
Support costs are those costs incurred directly in the support of expenditure on the objects of the charity. They include governance costs. Which are those incurred in connection with the administration of the charity and compliance with constitutional and statutory requirements.
All resources expended are inclusive of irrecoverable VAT.
1.5 Fixed assets
Fixed Assets are stated at cost less accumulated depreciation.
Computer equipment 15% reducing balance
1.6 Going concern basis
The directors of the charitable company are satisfied that there are no material uncertainties about the charity’s ability to continue as a going concern.
2 Donations
| Donations | ||||
|---|---|---|---|---|
| Unrestricted funds | Restricted funds | Total funds | Total funds | |
| 2023 | 2023 | 2023 | 2022 | |
| £ | £ | £ | £ | |
| Donations | 88,108 | 8,500 | 96,608 | 65,943 |
| Grants receivable | - | - | - | 8,181 |
| 88,108 | 8,500 | 96,608 | 74,124 | |
| Other trading activities Fundraising events Kickstart |
Unrestricted funds 2023 £ 81,637 - |
Restricted funds 2023 £ - - |
Total funds 2023 £ 81,637 - |
Total funds 2022 £ 69,581 13,978 |
| 81,637 | - | 81,637 | 83,559 | |
| Expenditure on fundraising Fundrasing activities |
Unrestricted funds 2023 £ 26,042 |
Restricted funds 2023 £ - |
Total funds 2023 £ 26,042 |
Total funds 2022 £ 23,654 |
3 Other trading activities
4 Expenditure on fundraising
14
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital) Notes to the financial statements (continued) Year ended 31 December 2023
| 5 Analysis of resources expended by activities Direct costs Support costs Total funds 2023 2023 2023 £ £ £ Charitable activities 71,135 69,271 140,406 6 Support costs 2023 £ Wages and salaries 60,255 Employers national insurance 1,019 Premisies costs 733 Office running costs 5,124 Bank interest and charges 15 Accountancy 1,225 Legal fees 743 Depreciation 157 69,271 7 Net income This is stated after charging 2023 £ Depreciation 157 8 Staff costs 2023 £ Wages and salaries 60,255 Employers national insurance 1,019 61,274 The average number of employees during the year was 2023 Administration 3 No employee received remuneration in excess of £60,000. |
Total funds 2022 £ 141,778 2022 £ 73,176 2,132 299 4,337 - 1,226 391 185 81,746 2022 £ 185 2022 £ 73,176 2,132 75,308 2022 3 |
|---|---|
No trustees received any remuneration or re-imbursement of expenses
15
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital) Notes to the financial statements (continued) Year ended 31 December 2023
9 Tangable fixed assets
| Cost At 1 January 2023 Additions At 31 December 2023 Depreciation At 1 January 2023 Charge for year At 31 December 2023 Net book value At 31 December 2023 At 31 December 2022 10 Creditors: Amonts due within one year Other taxes and social security Accruals |
2023 £ - 700 700 |
Computer equipment 2,810 - 2,810 1,762 157 1,919 891 1,048 |
Total 2,810 - 2,810 1,762 157 1,919 891 1,048 2022 £ 1,809 700 2,509 |
|---|---|---|---|
16
DRAGONFLY CANCER TRUST LTD
(a company limited by guarantee without share capital) Notes to the financial statements (continued) Year ended 31 December 2023
11 Statement of funds
| Statement of funds | ||||
|---|---|---|---|---|
| Resources | ||||
| 31 December 2022 | Income resources | expended | 31 December 2023 | |
| £ | £ | £ | £ | |
| Designated funds | ||||
| Capital fund | 1,048 | - | 157 | 891 |
| Operating fund | 65,000 | - | - | 65,000 |
| 66,048 | - | 157 | 65,891 | |
| General funds | ||||
| General funds | 12,899 | 169,745 | 152,791 | 29,853 |
| Unrestricted funds | 78,947 | 169,745 | 152,948 | 95,744 |
| Restricted funds G Works Nitin Shukla Caberet v Cancer Local Giving Rothlay Trust Freemasons |
- - - - - 5,000 |
2,000 100 5,000 500 900 - |
2,000 100 5,000 500 900 5,000 |
- - - - - - |
| 5,000 | 8,500 | 13,500 | - | |
| Total funds | 83,947 | 178,245 | 166,448 | 95,744 |
| Designated funds Capital fund Operating fund |
31 December 2021 £ 1,233 65,000 |
Income resources £ - - |
Resources expended £ 185 - |
31 December 2022 £ 1,048 65,000 |
| 66,233 | - | 185 | 66,048 | |
| General funds | ||||
| General funds | 15,193 | 138,602 | 140,896 | 12,899 |
| Unrestricted funds | 81,426 | 138,602 | 141,081 | 78,947 |
| Restricted funds Newcastle Building Society Kickstart Etro Properties Limited Rothlay Trust Freemasons |
270 - - - 10,000 |
3,000 13,978 1,103 1,000 - |
3,270 13,978 1,103 1,000 5,000 |
- - 5,000 |
| 10,270 | 19,081 | 24,351 | 5,000 | |
| Total funds | 91,696 | 157,683 | 165,432 | 83,947 |
The Capital Fund represents the net book value of the assets held and is not therefore readily realisable
The Operating Fund has been established to ensure the short term continuation of the charity in the event of significantly reduced income.